Migraine Drugs Market Exhaustive Analysis with USD $2.190 Billion, Highest CAGR till 2025
Surge in awareness about migraine treatment and prevention across the globe is anticipated to significantly drive the growth of the migraine drugs market.
NE WIN SIVERS DRIVE, PROVINCE: - PORTLAND, UNITED STATES, December 14, 2021 /EINPresswire.com/ -- The Migraine Drugs Market1 was valued at $1,713 million in 2017 and is expected to reach $2,190 million by 2025, growing at a CAGR of 3.1% from 2018 to 2025. North America is anticipated to be the highest revenue contributor throughout the forecast period. Migraine is characterized by a recurrent throbbing headache, which affects only one side of the head. It is accompanied by vomiting, nausea, and even disturbed vision in some cases.
Increase in prevalence of migraine, rapid rise in female population, and surge in awareness among patients for migraine treatment & prevention drive the growth of the global migraine drugs market. However, side effects of migraine drugs are expected to limit the market growth. Conversely, emerging new therapies/drugs for migraine treatment and growth opportunities in the emerging nations are expected to present opportunities for the market growth during the forecast period.
๐๐ผ๐ฟ ๐ฅ๐ถ๐ด๐ต๐ ๐ฃ๐ฒ๐ฟ๐๐ฝ๐ฒ๐ฐ๐๐ถ๐๐ฒ ๐ฎ๐ป๐ฑ ๐๐ผ๐บ๐ฝ๐ฒ๐๐ถ๐๐ถ๐๐ฒ ๐๐ป๐๐ถ๐ด๐ต๐๐, ๐๐ฒ๐ ๐ฆ๐ฎ๐บ๐ฝ๐น๐ฒ ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐ ๐ฎ๐: https://www.alliedmarketresearch.com/request-sample/2811
By type, abortive medicines accounted for more than three-fourths share of the global migraine drugs market in 2017. Furthermore, by route of administration, the oral segment is anticipated to grow at the highest rate of 3.4% during the forecast period.
North America was the leading revenue contributor to the global market in 2017, owing to surge in demand for better healthcare along with effective government reforms for awareness towards migraine & its prevention. However, Asia-Pacific is expected to grow at the highest CAGR of 4.4% from 2018 to 2025, due to improvements in healthcare infrastructure and rise in demand for better healthcare facilities.
๐๐ผ๐บ๐ฝ๐ฟ๐ฒ๐ต๐ฒ๐ป๐๐ถ๐๐ฒ ๐ฐ๐ผ๐บ๐ฝ๐ฒ๐๐ถ๐๐ถ๐๐ฒ ๐ฎ๐ป๐ฎ๐น๐๐๐ถ๐ ๐ฎ๐ป๐ฑ ๐ฝ๐ฟ๐ผ๐ณ๐ถ๐น๐ฒ๐ ๐ผ๐ณ ๐บ๐ฎ๐ท๐ผ๐ฟ ๐บ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐ฝ๐น๐ฎ๐๐ฒ๐ฟ๐, ๐๐๐ฐ๐ต ๐ฎ๐
Abbott Laboratories, Allergan Plc., AstraZeneca, Eisai Co., Ltd., Endo International Plc., GlaxoSmithKline Plc., Impax Laboratories, Johnson & Johnson, Merck & Co., and Pfizer Inc.
The other players in the value chain (not included in the report) include Novartis International AG, Teva Pharmaceutical Industries Limited, and Sanofi SA.
๐ท ๐๐ผ๐๐ถ๐ฑ-๐ญ๐ต ๐ฆ๐ฐ๐ฒ๐ป๐ฎ๐ฟ๐ถ๐ผ:
1) The Covid-19 pandemic and followed by lockdown has affected several manufacturing industries.
2) The prolonged lockdown resulted in a disrupted supply chain and increased the prices of raw materials.
3) However, as the world has been recovering from the pandemic, the market is estimated to get back on track.
๐๐ฒ๐ ๐๐ฒ๐๐ฎ๐ถ๐น๐ฒ๐ฑ ๐๐ผ๐๐ถ๐ฑ-๐ญ๐ต ๐๐บ๐ฝ๐ฎ๐ฐ๐ ๐๐ป๐ฎ๐น๐๐๐ถ๐ ๐ฎ๐: https://www.alliedmarketresearch.com/request-for-customization/2811?reqfor=covid
โฏ ๐๐ฒ๐ ๐๐ฒ๐ป๐ฒ๐ณ๐ถ๐๐ ๐ณ๐ผ๐ฟ ๐ฆ๐๐ฎ๐ธ๐ฒ๐ต๐ผ๐น๐ฑ๐ฒ๐ฟ๐
โฆThe study provides an in-depth analysis of the Migraine Drugs Market along with the current trends and future estimations to elucidate the imminent investment pockets.
โฆIt offers Migraine Drugs Market analysis from 2018 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
โฆA comprehensive analysis of four regions is provided to determine the prevailing opportunities.
โฆThe profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global Migraine Drugs Market growth.
๐๐ง๐ญ๐๐ซ๐๐ฌ๐ญ๐๐ ๐ข๐ง ๐๐ซ๐จ๐๐ฎ๐ซ๐ข๐ง๐ ๐ญ๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ? ๐๐ข๐ฌ๐ข๐ญ ๐๐๐ซ๐: https://www.alliedmarketresearch.com/purchase-enquiry/2811
๐๐ฟ๐ฒ๐พ๐๐ฒ๐ป๐๐น๐ ๐๐๐ธ๐ฒ๐ฑ ๐ค๐๐ฒ๐๐๐ถ๐ผ๐ป๐?
Q1. What are the leading market players active in Migraine Drugs Market?
Q2. What current trends will influence the market in the next few years?
Q3. What are the driving factors, restraints, and opportunities in the market?
Q4. What are the projections for the future that would help in taking further strategic steps?
๐๐๐ฒ๐ป๐๐ฒ ๐๐ฎ๐๐ถ๐ฐ ๐ฃ๐น๐ฎ๐ป | ๐๐ถ๐ฏ๐ฟ๐ฎ๐ฟ๐ ๐๐ฐ๐ฐ๐ฒ๐๐ | ๐ญ ๐ฌ๐ฒ๐ฎ๐ฟ ๐ฆ๐๐ฏ๐๐ฐ๐ฟ๐ถ๐ฝ๐๐ถ๐ผ๐ป |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter
โWe have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.โ
๐ง๐ฟ๐ฒ๐ป๐ฑ๐ถ๐ป๐ด ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐๐ ๐ถ๐ป ๐๐ฒ๐ฎ๐น๐๐ต๐ฐ๐ฎ๐ฟ๐ฒ ๐๐ป๐ฑ๐๐๐๐ฟ๐:
Medical Laser Market - Global Opportunity & Industry Forecast, 20262
Minimally Invasive Surgery Market3 - Global Opportunity & Industry Forecast, 2030
๐๐๐จ๐ฎ๐ญ ๐๐ฌ
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
David Correa
Allied Analytics LLP
+1 503-894-6022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
1 https://www.alliedmarketresearch.com/migraine-drugs-market
2 https://www.alliedmarketresearch.com/medical-lasers-market
3 https://www.alliedmarketresearch.com/minimally-invasive-surgical-instruments-market